Arexvy Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Resp syncytial virus (RSV) vaccine [recombinant, adjuvanted (RSVPreF3 antigen, AS01_E adjuvant system)]

Indications/Uses

Active immunisation for prevention of lower resp tract disease caused by RSV in adults ≥60 yr.

Click to view Arexvy detailed prescribing information

Dosage/Direction for Use

0.5 mL single dose IM inj.

Click to view Arexvy detailed prescribing information

Overdosage

View Arexvy overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Arexvy detailed prescribing information

Special Precautions

Not to be administered intravascularly or intradermally. Postpone vaccination in individuals suffering from acute severe febrile illness. Thrombocytopenia or any coagulation disorder; anxiety-related reactions eg, vasovagal reactions (syncope), hyperventilation or stress-related reactions. Patients on immunosuppressive treatment or w/ immunodeficiency. May affect ability to drive & use machines. Not recommended during pregnancy & lactation. Childn.

Click to view Arexvy detailed prescribing information

Use In Pregnancy & Lactation

Click to view Arexvy detailed prescribing information

Adverse Reactions

Headache; myalgia, arthralgia; inj site pain, fatigue. Inj site erythema & swelling, fever, chills.

Click to view Arexvy detailed prescribing information

Drug Interactions

Administer at different inj sites w/ another inj vaccine.

Click to view Arexvy detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Arexvy detailed prescribing information

Storage

View Arexvy storage conditions for details to ensure optimal shelf-life.

Description

View Arexvy description for details of the chemical structure and excipients (inactive components).

Action

View Arexvy mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BX05 - respiratory syncytial virus vaccines ; Belongs to the class of other viral vaccines. Used for active immunization against respiratory syncytial virus.

Regulatory Classification

Presentation/Packing

Form

Arexvy powd & susp for susp for inj (vial) 120 mcg/0.5 mL

Packing/Price

1's

Arexvy

respiratory syncytial virus vaccine

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma